高尔基体
生物
脱氮酶
糖基化
细胞生物学
泛素
自噬
调节器
癌症研究
泛素连接酶
癌细胞
翻译后调节
下调和上调
信号转导
糖基转移酶
染色体易位
HEK 293细胞
N-连接糖基化
细胞
平衡
受体
碎片(计算)
信号转导衔接蛋白
乳腺癌
串扰
基因剔除小鼠
转录调控
肿瘤进展
癌症
转运蛋白
溶酶体
作者
Jiaxin Xu,Yang Cai,Yuting Zhang,Jiejie Yang,Yixian Cui
标识
DOI:10.1038/s44318-026-00947-1
摘要
Selective autophagy of the Golgi apparatus (Golgiphagy) is essential for Golgi quality control, yet its regulation and physiological functions remain poorly understood. Here, we identify the deubiquitinase USP28 as an upstream regulator of the Golgiphagy receptor TM9SF3. USP28 removes degradative K48-linked ubiquitin chains from TM9SF3, preventing its proteasomal degradation and sustaining Golgiphagy under nutrient and Golgi stresses. CRM1-dependent nuclear export enables the stress-induced translocation of USP28 to the Golgi, where it stabilizes TM9SF3, promoting Golgi fragmentation and autophagic clearance. Loss of USP28 or TM9SF3 impairs Golgiphagy, disrupts glycosylation fidelity, and inhibits breast cancer cell proliferation. Proteomic and functional analyses identify the glycosyltransferase MGAT5 as a selective TM9SF3-dependent Golgiphagy cargo, revealing how this pathway maintains glycosylation homeostasis. In syngeneic tumor models, USP28 knockout or pharmacological inhibition reduces TM9SF3 abundance, compromises Golgiphagy, perturbs glycosylation, and markedly suppresses tumor growth-effects restored by wild-type but not LC3-binding-deficient TM9SF3. Together, these findings reveal a USP28-TM9SF3-Golgiphagy axis that couples ubiquitin signaling to Golgi glycosylation control and represents a therapeutically targetable pathway for breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI